Surgepays is trading 6.25% down at $0.15 during the September 15, 2026 session, with no new company-specific announcement identified to explain the decline.
- The latest notable corporate development remains the September 10 sale of ClearLine-related assets to GPO Plus for $27.5 million.
- Broader markets are modestly lower, but available evidence does not establish a clear direct catalyst for Surgepays.